. Estimates of the effects and quality ratings for the comparison of drugs to induce clinical remission for active distal UC patients. *risk of bias; †Inconsistency; ‡Imprecision; §Indirectness [intransitivity] . † †Cannot be estimated because the drug was not connected in a loop in the evidence network. ¶ Contributing direct evidence of moderate quality. **Contributing direct evidence of low or very low quality. ‡ ‡Indirectness because of the questionable comparability of the trial populations to the target population of NMA or because of intransitivity. § §Greater precision Ratings: High: We have enough confidence in the evidence rating. Moderate: We have moderate confidence in the evidence rating. Low: We have limited confidence in the evidence rating and the true effect might be substantially different from the estimate of the effect. Very low: We have no certainty of confidence in the evidence rating. Table S2 . Estimates of the effects and quality ratings for the comparison of drugs to induce endoscopic remission for active distal UC patients. *risk of bias; †Inconsistency; ‡Imprecision; §Indirectness [intransitivity] . † †Cannot be estimated because the drug was not connected in a loop in the evidence network. ¶ Contributing direct evidence of moderate quality. **Contributing direct evidence of low or very low quality. ‡ ‡Indirectness because of the questionable comparability of the trial populations to the target population of NMA or because of intransitivity. § §Greater precision Ratings: High: We have enough confidence in the evidence rating. Moderate: We have moderate confidence in the evidence rating. Low: We have limited confidence in the evidence rating and the true effect might be substantially different from the estimate of the effect. Very low: We have no certainty of confidence in the evidence rating.
